Curocell (372320.KQ) — Stock Score Summary

Curocell (372320.KQ) has a MoatMap StockRank of 2/100 based on Quality (11/100), Value (33/100), and Momentum (31/100) factor scores. The current signal is STRONG SELL.

Curocell Inc., a cell gene therapy development company, engages in the development and manufacturing of pharmaceuticals.

Key Financial Metrics

Price$18.60
Market Cap$285M
Price/Book80.84
Return on Equity-203.8%
Return on Invested Capital-328.7%
Debt/Equity196.44
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-4K

Curocell operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Curocell’s (372320.KQ) StockRank?
MoatMap’s StockRank for Curocell (372320.KQ) is 2/100, with a Strong Sell signal. It is a composite of Quality (11), Value (33), and Momentum (31) factor ranks across MoatMap’s 19,000+ stock universe.
Does Curocell have an economic moat?
Curocell (372320.KQ) has a Quality factor score of 11/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Curocell a buy, hold, or sell?
MoatMap’s current signal for Curocell (372320.KQ) is Strong Sell, based on a StockRank of 2/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Curocell in?
Curocell (372320.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks372320.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock